OpenAI is moving away from models that require heavy hand-holding and toward systems that can better infer the user’s goal, ...

Foreign portfolio investors have sold Indian equities worth $29.5 billion so far this year, versus $18.9 billion over all of last year. India's growth remains strong, but the economy faces headwinds ...

Tap Here To Add Soap Opera Digest As A Trusted Source Add as a preferred source on Google General Hospital star Kirsten Storms (Maxie) has taken to social media to address her future with the show.

Well, good morning, everyone, and thanks for joining. I'm the analyst, Tim Mulrooney that covers APi Group here at William Blair. I'm re ration inform you that for a complete list of research ...

TMZ says that in filing for the emergency order, Barash detailed his worry over Storms’s mental health in the court documents, citing his “great concern [for her] ability to adequately care for the ...

Q1 2026 API usage growth accelerated nearly 4x quarter-over-quarter, as AI-driven and agent-based market participation gained momentum Alpaca, a global leader in brokerage infrastructure APIs, today ...

Singapore’s growth is poised to moderate as its export-driven model is strained by geopolitical tensions and a fragmenting global trading system, though it could draw support from opportunities in the ...

EXCLUSIVE: Jonathan Bennett is joining General Hospital in the role of Joe Fitzpatrick, making his debut on the ABC soap opera starting in May. Bennett is best known for playing the heartthrob Aaron ...

Are you a subscriber to Anthropic's Claude Pro ($20 monthly) or Max ($100-$200 monthly) plans and use its Claude AI models and products to power third-party AI agents like OpenClaw? If so, you're in ...

March 5 (Reuters) - A temporary surge in oil prices to $100 per barrel could slow global growth by 0.4 percentage point, Goldman Sachs analysts said on Thursday, as a widening conflict ‌in Iran chokes ...

The US FDA has approved Novo Nordisk’s once-weekly growth hormone somapacitan-beco (Sogroya) for three new pediatric indications. The approval was based on findings from the first year of REAL8, a ...

Management expects 2026 full-year reported net revenues of $8.4 billion to $8.6 billion, with organic growth of 5% at the midpoint. Full-year adjusted EBITDA is projected at $1.14 billion to $1.20 ...